ATYR PHARMA
aTyr Pharma is a biotherapeutics company that discovers and develops protein biologics for human therapeutics. The company has established a dominant intellectual property estate surrounding Physiocrine-based compositions and potential therapeutic applications. aTyr’s key programs are focused on immunomodulation disorders in the areas of inflammation and immunity and are in preclinical development. The company's primary focus is ATYR1923, a clinical-stage product candidate which binds to the... neuropilin-2 receptor and is designed to down-regulate immune engagement in interstitial lung diseases. The privately held biotech was founded by The Scripps Research Institute Professor Paul Schimmel, a leading aminoacyl tRNA synthetase scientist, and is backed by top life sciences investors Alta Partners, Cardinal Partners, Domain Associates and Polaris Ventures.
ATYR PHARMA
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2005-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.atyrpharma.com
Total Employee:
51+
Status:
Active
Contact:
(858) 731-8389
Email Addresses:
[email protected]
Total Funding:
402.5 M USD
Technology used in webpage:
Domain Not Resolving Google Maps IPv6 ReCAPTCHA CrUX Top 50m ASP.NET IIS ASP.NET 4.0 Vimeo ASP.NET Ajax
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Amunix
Amunix is a biopharmaceutical company intended to discover, design, and develop novel biologics, protein, and peptide therapeutics.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
MediciNova
MediciNova is a biopharmaceutical company that acquires and develops novel, small-molecule therapeutics.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Viking Global Investors
Viking Global Investors investment in Post-IPO Equity - aTyr Pharma
Redmile Group
Redmile Group investment in Post-IPO Equity - aTyr Pharma
EcoR1 Capital
EcoR1 Capital investment in Post-IPO Equity - aTyr Pharma
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - aTyr Pharma
Solar capital
Solar capital investment in Post-IPO Debt - aTyr Pharma
Domain Associates
Domain Associates investment in Series E - aTyr Pharma
EcoR1 Capital
EcoR1 Capital investment in Series E - aTyr Pharma
Polaris Venture Capital
Polaris Venture Capital investment in Series E - aTyr Pharma
Alta Partners
Alta Partners investment in Series E - aTyr Pharma
Cardinal Partners
Cardinal Partners investment in Series E - aTyr Pharma
Key Employee Changes
Official Site Inspections
http://www.atyrpharma.com Semrush global rank: 2.95 M Semrush visits lastest month: 5.33 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "aTyr Pharma"
aTyr Pharma - Wikipedia
ATyr Pharma is a public biotherapeutics company (Nasdaq: LIFE) that is focused on researching the extracellular functionality and signaling pathways of tRNA synthetases. The company's lead product candidate, ATYR1923, is a selective modulator of Neuropilin-2 (NRP2) that downregulates both the innate and adaptive immune …See details»
About Us - aTyr Pharma
ATyr is a clinical stage biotechnology company leveraging evolutionary intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation. tRNA synthetases …See details»
aTyr Pharma - Crunchbase Company Profile & Funding
ATyr Pharma is a biotherapeutics company that discovers and develops protein biologics for human therapeutics. The company has established a dominant intellectual property estate …See details»
Board of Directors - aTyr Pharma
ATyr’s Board of Directors plays an important strategic role in guiding our vision as a biotech company driven by innovation and the discovery of breakthrough scientific discoveries. Each member has a demonstrated record of success in …See details»
aTyr Pharma - LinkedIn
ATyr Pharma (Nasdaq: LIFE) is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways. aTyr’s research and development ...See details»
aTyr Pharma Announces Second Quarter 2024 Results and …
Aug 13, 2024 For more information, please visit www.atyrpharma.com. Forward-Looking Statements. This press release contains forward-looking statements within the meaning of the …See details»
aTyr Pharma, Inc. (ATYR) Company Profile & Overview - Stock …
May 7, 2015 Company profile for aTyr Pharma, Inc. (ATYR) with a description, list of executives, contact details and other key facts.See details»
aTyr Pharma - Overview, News & Similar companies - ZoomInfo
May 2, 2024 Who is aTyr Pharma. aTyr is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways. aTyr's resea …See details»
aTyr Pharma - Craft
Aug 6, 2024 aTyr Pharma has 4 employees at their 1 location and $353 k in annual revenue in FY 2023. See insights on aTyr Pharma including office locations, competitors, revenue, …See details»
aTyr Pharma and FUJIFILM Diosynth Biotechnologies Announce ...
SAN DIEGO – November 30, 2021 – aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel …See details»
Leadership Team - aTyr Pharma
Our leadership team has a proven track record of discovering and developing breakthrough medicines from new areas of biology. We are utilizing our combined experiences and …See details»
aTyr Pharma, Inc. (ATYR) Stock Price, Quote & News - Stock Analysis
5 days ago Website https://www.atyrpharma.com. Full Company Profile. Financial Performance. In 2023, aTyr Pharma's revenue was $353,000, a decrease of -96.60% compared to the …See details»
News Releases | Investor Relations - aTyr Pharma
Oct 14, 2024 Study to explore role of the Company’s anti-NRP2 antibodies in glioblastoma multiforme (GBM), the most common type of primary brain cancer. SAN DIEGO , July 30, …See details»
aTyr Pharma Advances Development of Lead Therapeutic …
SAN DIEGO, Jan. 13, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines …See details»
Working at aTyr - aTyr Pharma
Patients in need provide tremendous drive and meaning to what we do at aTyr. Our shared values motivate our dedicated team towards achieving our mission to translate discoveries from our …See details»
aTyr Pharma Announces Third Quarter 2022 Results and Provides …
Nov 10, 2022 For more information, please visit www.atyrpharma.com. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the …See details»
aTyr Pharma, Inc. (ATYR) Statistics & Valuation Metrics - Stock …
Nov 7, 2024 Detailed statistics for aTyr Pharma, Inc. (ATYR) stock, including valuation metrics, financial numbers, share information and more.See details»
aTyr Pharma, Inc. (ATYR) Stock Price, News, Quote & History
Find the latest aTyr Pharma, Inc. (ATYR) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
aTyr Pharma to Present at the Oppenheimer Fall Healthcare Life …
SAN DIEGO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines …See details»